Willis Johnson & Associates’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$513K Buy
2,099
+587
+39% +$137K 0.03% 112
2025
Q4
$313K Buy
1,512
+29
+2% +$5.74K 0.02% 139
2025
Q3
$275K Sell
1,483
-142
-9% -$24.3K 0.02% 146
2025
Q2
$248K Sell
1,625
-142
-8% -$21.8K 0.02% 147
2025
Q1
$293K Buy
+1,767
New +$276K 0.02% 129
2024
Q4
Sell
-1,489
Closed -$241K 168
2024
Q3
$241K Buy
+1,489
New +$237K 0.02% 140
2024
Q2
Sell
-1,589
Closed -$251K 161
2024
Q1
$251K Sell
1,589
-435
-21% -$69.2K 0.02% 127
2023
Q4
$317K Buy
+2,024
New +$310K 0.03% 106
2023
Q3
Sell
-1,294
Closed -$214K 135
2023
Q2
$214K Buy
+1,294
New +$209K 0.02% 120
2023
Q1
Sell
-1,189
Closed -$210K 122
2022
Q4
$210K Sell
1,189
-69
-5% -$11.9K 0.03% 106
2022
Q3
$205K Sell
1,258
-132
-9% -$22.3K 0.03% 96
2022
Q2
$247K Buy
+1,390
New +$248K 0.03% 88

Other funds holding JNJ

Willis Johnson & Associates's JNJ Position: Q1 2026 in Review

Willis Johnson & Associates increased its Johnson & Johnson (JNJ) stake by 39% in Q1 2026, buying an estimated $137K and bringing the position to 2,099 shares worth $513K. The position accounts for 0.03% of the portfolio, ranked #112.

Willis Johnson & Associates first reported a position in JNJ in Q2 2022 and has held it in 12 quarters since. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Willis Johnson & Associates held 2,099 shares of Johnson & Johnson worth $513K as of Q1 2026.
  • Willis Johnson & Associates bought 587 Johnson & Johnson shares in Q1 2026, an estimated $137K.
  • Johnson & Johnson made up 0.03% of Willis Johnson & Associates's portfolio in Q1 2026, its #112 holding.
  • Willis Johnson & Associates first reported a position in Johnson & Johnson in Q2 2022 and has held it in 12 quarters since.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Willis Johnson & Associates's 13F filing for Q1 2026, filed 23 Apr 2026.